Advertisement
MINISYMPOSIUM: the Science of Head Transplantation and Spinal Cord Reconstruction| Volume 160, ISSUE 1, P5-10, July 01, 2016

Brain protection during cephalosomatic anastomosis

Published:April 30, 2016DOI:https://doi.org/10.1016/j.surg.2016.01.026
      Cephalosomatic anastomosis requires neuroprotective techniques, such as deep hypothermia, to preserve brain activity. Despite the failure of pharmacologic neuroprotection, new strategies, including ischemic pre- and postconitioning and the use of Perftoran, have to be explored to complement hypothermia. This article summarizes the field of brain protection during CSA and these promising strategies.
      To read this article in full you will need to make a payment
      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Canavero S.
        HEAVEN: The head anastomosis venture project outline for the first human head transplantation with spinal linkage (GEMINI).
        Surg Neurol Int. 2013; 4: S335-S342
        • White R.J.
        Cerebral hypothermia and circulatory arrest. Review and commentary.
        Mayo Clin Proc. 1978; 53: 450-458
        • Ren X.P.
        • Ye Y.J.
        • Li P.W.
        • et al.
        Head transplantation in mouse model.
        CNS Neurosci Ther. 2015; 21: 615-618
        • Weng Y.
        • Sun S.
        Therapeutic hypothermia after cardiac arrest in adults: Mechanism of neuroprotection, phases of hypothermia, and methods of cooling.
        Crit Care Clin. 2012; 28: 231-243
        • Wu T.C.
        • Grotta J.C.
        Hypothermia for acute ischaemic stroke.
        Lancet Neurol. 2013; 12: 275-284
        • Han Z.
        • Liu X.
        • Luo Y.
        • Ji X.
        Therapeutic hypothermia for stroke: Where to go?.
        Exp Neurol. 2015; 272: 67-77
        • Els T.
        • Oehm E.
        • Voigt S.
        • et al.
        Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke.
        Cerebrovasc Dis. 2006; 21: 79-85
        • Rosomoff H.L.
        • Holaday D.A.
        Cerebral blood flow and cerebral oxygen consumption during hypothermia.
        Am J Physiol. 1954; 179: 85-88
        • Polderman K.H.
        Mechanisms of action, physiological effects, and complications of hypothermia.
        Crit Care Med. 2009; 37: S186-S202
        • Gonzalez-Ibarra F.P.
        • Varon J.
        • Lopez-Meza E.G.
        Therapeutic hypothermia: Critical review of the molecular mechanisms of action front.
        Neurology. 2011; 2: 4
        • White R.J.
        Hypothermia preservation and transplantation of brain.
        Resuscitation. 1975; 4: 197-210
        • Hindman B.J.
        Hypothermia in neurological and cardiac anethesia.
        in: Mayer S.A. Sessler D.I. Therapeutic hypothermia. Marcel Dekker, New York2005: 525-606
        • Mack W.J.
        • Ducruet A.F.
        • Angevine P.D.
        • Komotar R.J.
        • Shrebnick D.B.
        • Edwards N.M.
        • et al.
        Deep hypothermic circulatory arrest for complex cerebral aneurysms: Lessons learned.
        Neurosurgery. 2007; 60: 815-827
        • De Georgia M.
        • Deogaonkar A.
        • Merrill T.L.
        Methods to induce hypothermia.
        in: Mayer S.A. Sessler D.I. Therapeutic hypothermia. Marcel Dekker, New York2005: 293-322
        • Karnatovskaia L.V.
        • Wartenberg K.E.
        • Freeman W.D.
        Therapeutic hypothermia for neuroprotection: History, mechanisms, risks, and clinical applications.
        Neurohospitalist. 2014; 4: 153-163
        • De Georgia M.A.
        • Krieger D.W.
        • Abou-Chebl A.
        • et al.
        Cooling for acute ischemic brain damage (COOL AID): A feasibility trial of endovascular cooling.
        Neurology. 2004; 63: 312-317
        • Harris B.A.
        • Andrews P.J.
        Direct brain cooling.
        in: Mayer S.A. Sessler D.I. Therapeutic hypothermia. Marcel Dekker, New York2005: 323-386
        • Choi J.H.
        • Marshall R.S.
        • Neimark M.
        • et al.
        Selective brain cooling with endovascular intracarotid infusion of cold saline: A pilot feasibility study.
        AJNR Am J Neuroradiol. 2010; 31: 928-934
        • Esposito E.
        • Ebner M.
        • Ziemann U.
        • Poli S.
        In cold blood: Intraarterial cold infusions for selective brain cooling in stroke.
        J Cereb Blood Flow Metab. 2014; 34: 743-752
        • Matsuwaka R.
        • Sakakibara T.
        • Hori T.
        • Shinohara N.
        Initial experience with cool head, warm body perfusion in aortic arch surgery.
        J Cardiovasc Surg. 1998; 13: 463-467
        • Ji Y.B.
        • Wu Y.M.
        • Ji Z.
        • et al.
        Pan interrupted intracarotid artery cold saline infusion as an alternative method for neuroprotection after ischemic stroke.
        Neurosurg Focus. 2012; 33: E10
        • Deng J.
        • Lei C.
        • Chen Y.
        • et al.
        Neuroprotective gases—Fantasy or reality for clinical use?.
        Prog Neurobiol. 2014; 115: 210-245
        • Chen F.
        • Qi Z.
        • Luo Y.
        • et al.
        Non-pharmaceutical therapies for stroke: Mechanisms and clinical implications.
        Prog Neurobiol. 2014; 115: 246-269
        • Huang L.
        • Applegate P.A.
        • Gatling J.W.
        • et al.
        A systematic review of neuroprotective strategies after cardiac arrest: From bench to bedside (part II-comprehensive protection).
        Med Gas Res. 2014; 4: 10
        • Sayouri H.
        • Boudier A.
        • Vigneron C.
        • et al.
        Hydrogen sulfide: A promising therapy in neuroprotection following cardiac arrest?.
        Ann Pharm Fr. 2015; 73: 401-410
        • Yenari M.A.
        • Han H.S.
        Neuroprotective mechanisms of hypothermia in brain ischaemia.
        Nat Rev Neurosci. 2012; 13: 267-278
        • Murry E.
        • Jennings R.B.
        • Reimer K.A.
        Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium.
        Circulation. 1986; 74: 1124-1136
        • Schurr A.
        • Reid K.H.
        • Tseng M.T.
        • West C.
        • Rigor B.M.
        Adaptation of adult brain tissue to anoxia and hypoxia in vitro.
        Brain Res. 1986; 374: 244-248
        • Kirino T.
        Ischemic tolerance.
        J Cereb Blood Flow Metab. 2002; 22: 1283-1296
        • Gidday J.M.
        Cerebral preconditioning and ischaemic tolerance.
        Nat Rev Neurosci. 2006; 7: 437-448
        • Obrenovitch T.P.
        Molecular physiology of preconditioning-induced brain tolerance to ischemia.
        Physiol Rev. 2008; 88: 211-247
        • Zhao H.
        Ischemic postconditioning as a novel avenue to protect against brain injury after stroke.
        J Cereb Blood Flow Metab. 2009; 29: 873-885
        • Zhao H.
        • Ren C.
        • Chen X.
        • Shen J.
        From rapid to delayed and remote postconditioning: The evolving concept of ischemic postconditioning in brain ischemia.
        Curr Drug Targets. 2012; 13: 173-187
        • Jiang X.
        • Shi E.
        • Nakajima Y.
        • Sato S.
        Postconditioning, a series of brief interruptions of early reperfusion, prevents neurologic injury after spinal cord ischemia.
        Ann Surg. 2006; 244: 148-153
        • Wang J.Y.
        • Shen J.
        • Gao Q.
        • Ye Z.G.
        • Yang S.Y.
        • Liang H.W.
        • et al.
        Ischemic postconditioning protects against global cerebral ischemia/reperfusion-induced injury in rats.
        Stroke. 2008; 39: 983-990
        • Maevsky E.
        • Ivanitsky G.
        • Bogdanova L.
        • Axenova O.
        • Karmen N.
        Clinical results of Perftoran application: Present and future.
        Artif Cells Blood Substit Immobil Biotechnol. 2005; 33: 37-46
      1. Kolsanov AV, Mironov AA, Neljubina NE, Yaremin BI. Apnea oxygenation test safety and accessibility with the perftoran solution. Organ preservation and procurement. A75.23, Transplantation Society International Congress, 2010. Available from: https://www.tts.org/component/tts/?view=presentation&id=2992.

        • Reznik O.N.
        • Bagnenko S.F.
        • Loginov I.V.
        • et al.
        The use of oxygenated perfluorocarbonic emulsion for initial in situ kidney perfusion.
        Transplant Proc. 2008; 40: 1027-1028
        • Zakharov V.V.
        Results of the use of perftoran for anti-ischemic protection of renal transplant.
        Klin Khir. 1997; 1 ([in Russian]): 24-26
        • Putintsev A.M.
        • Sergeev V.N.
        • Filip'ev D.E.
        • et al.
        Feasibility study of perftoran for protection of the brain from ischaemia in operations on extracranial arteries.
        Angiol Sosud Khir. 2008; 14 ([in Russian]): 31-36
        • Canavero S.
        • Bonicalzi V.
        • Narcisi P.
        Safety of magnesium-lidocaine combination for severe head injury: The Turin LidoMag pilot study.
        Surg Neurol. 2003; 60: 165-169
        • Gonzalez-Lima F.
        • Auchter A.
        Protection against neurodegeneration with low-dose methylene blue and near-infrared light.
        Front Cell Neurosci. 2015; 9: 179
        • Turner A.R.
        • Duong C.D.
        • Good D.J.
        Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy.
        Clin Oncol (R Coll Radiol). 2003; 15: 435-439